BioCentury | Jun 4, 2019
Distillery Therapeutics

Dual inhibition of CDK4 and CDK6 for pulmonary arterial hypertension

...Theo Schermuly, Justus-Liebig University of Giessen, Giessen, Germany email: ralph.schermuly@innere.med.uni-giessen.de Claire Quang Ibrance (Brand), PD-0332991 (Compound #), palbociclib (Generic), Ibrance (Other) Justus-Liebig University of Giessen Cyclin...
BioCentury | Dec 21, 2015
Emerging Company Profile

New purpose in flu

...Ludwig, Rolf Naumann, Oliver Planz, Stephan Pleschka University collaborators: University of Tübingen, University of Münster, Justus-Liebig University of Giessen...
BioCentury | Apr 29, 2013
Company News

Activaero, Justus-Liebig University of Giessen deal

...university in late 2010 to develop therapies for pulmonary diseases. Activaero GmbH , Gemuenden, Germany Justus-Liebig University of Giessen...
Items per page:
1 - 3 of 3
BioCentury | Jun 4, 2019
Distillery Therapeutics

Dual inhibition of CDK4 and CDK6 for pulmonary arterial hypertension

...Theo Schermuly, Justus-Liebig University of Giessen, Giessen, Germany email: ralph.schermuly@innere.med.uni-giessen.de Claire Quang Ibrance (Brand), PD-0332991 (Compound #), palbociclib (Generic), Ibrance (Other) Justus-Liebig University of Giessen Cyclin...
BioCentury | Dec 21, 2015
Emerging Company Profile

New purpose in flu

...Ludwig, Rolf Naumann, Oliver Planz, Stephan Pleschka University collaborators: University of Tübingen, University of Münster, Justus-Liebig University of Giessen...
BioCentury | Apr 29, 2013
Company News

Activaero, Justus-Liebig University of Giessen deal

...university in late 2010 to develop therapies for pulmonary diseases. Activaero GmbH , Gemuenden, Germany Justus-Liebig University of Giessen...
Items per page:
1 - 3 of 3